Denmark, aided by the vice-coordinator Hans-Ulrich Weltzien from the Max-Planck Institute for Immunobiology and epigenetics, Freiburg Germany. the ultimate goal of the Sens-it-iv project was the development of a set of in vitro methods for the assessment of the skin and respiratory sensitization potential of chemicals and proteins. the level of development was intended to be at the point to enter the pre-validation phase. After 66 months of work, it could be concluded that the goal was largely accomplished. Several advanced methods were evaluated extensively, and for some of them a detailed standard operating procedure (SOP) was established for pre-validation purposes. Other, less advanced methods contributed to our understanding of the mechanisms driving sensitization as well.Several opportunities were employed to assure dissemination of results. During the course of the project, 44 newsletters were released, presenting the main achievements of the project. Fly-1 Introduction